| NCT ID | NCT05920733 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Michigan |
| Condition | Aging Well |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2023-07-05 |
| Primary Completion | 2026-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2023-07-05 with a primary completion date of 2026-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
HealthyLifetime (HL) is a person-centered program that enables older adults to maximize health and optimize functioning - the necessary requisite to successfully remaining independent in their preferred home setting as long as possible, i.e., to age in place.
Eligibility Criteria
Inclusion Criteria: * Be able to read, speak English and hear - but may use glasses or hearing aids, if needed; * Be able to tell us their age, their date of birth, address, and phone number, as well as write down and explain their health problems; * Have their own computer or iPad (Tablet) with an Internet connection, a working camera and microphone. and * Be able to use their computer/tablet to connect to video chat sessions like Zoom in a private space in their home or a private room. Exclusion Criteria: * People who, in the last month, have used the Emergency Room (ER) or stayed in the hospital. * Are not verified users of Medicaid Home Help services \[we will check with the Michigan Department of Health and Human Service to verify that you receive these services using your name, date of birth, and Medicaid identification number\]; * Have a new major health problem that they are seeing a doctor about more than once per month; * Have been told their illness is not curable; * Cannot remember their name, date of birth or their health problems; * Cannot use glasses or a hearing aid to see or hear well enough to read materials on the computer or talk to the nurse easily; and, * Do not have, or cannot use, a computer, iPad or other device with the Internet at home to use Zoom (e.g., internet streaming).
Contact & Investigator
Kathleen Potempa, PhD
STUDY DIRECTOR
University of Michigan
Frequently Asked Questions
Who can join the NCT05920733 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, studying Aging Well. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05920733 currently recruiting?
Yes, NCT05920733 is actively recruiting participants. Contact the research team at mcalarco@umich.edu for enrollment information.
Where is the NCT05920733 trial being conducted?
This trial is being conducted at Ann Arbor, United States.
Who is sponsoring the NCT05920733 clinical trial?
NCT05920733 is sponsored by University of Michigan. The principal investigator is Kathleen Potempa, PhD at University of Michigan. The trial plans to enroll 120 participants.